BioMark Diagnostics Inc. (OTCQB: BMKDF) is an oncology-focused company with advanced stage diagnostic technologies and anti-body based cancer treatment pipeline, according to the company’s website (see here: www.BioMarkDiagnostics.com). In this SNNLive On-Location, our host spoke with Rashid Ahmed, President and CEO of BioMark Diagnostics Inc. in New York City, NY.
In this video interview, Mr. Ahmed and our host discuss the following topics:
- Overview of BioMark Diagnostics Inc.
- Describes the company’s diagnostics technology
- Where the technology/science was developed
- What differentiates the company’s diagnostics technology and applications
- Mr. Ahmed’s background
For more information about BioMark Diagnostics Inc., go to: www.BioMarkDiagnostics.com
© 2017 Stock News Now
Supported by Superior Web Solutions